Perth-based burns treatment developer Clinical Cell Culture Ltd, or C3, has announced that lower-than-expected sales and approval delays will keep it from reaching its $5-7 million revenue target for the 2007 financial year.
Perth-based skins and burns treatment developer Clinical Cell Culture Ltd has announced that it has appointed Bob Atwill as its new chief executive officer and a director of the company.
